Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
J Virol. 2013 May;87(10):5858-67. doi: 10.1128/JVI.00174-13. Epub 2013 Mar 13.
Hepatitis C virus (HCV) proteins inhibit complement component expression, which may attenuate immunity against infection. In this study, we examined whether HCV regulates the membrane attack complex (MAC) via complement component C9. MAC is composed of C5b to C9 (C5b-9) and mediates cell lysis of invaded pathogens. Liver biopsy specimens from chronically HCV-infected patients exhibited a lower level of C9 mRNA expression than liver biopsy specimens from unrelated disease or healthy control human liver RNA. Hepatocytes infected with cell culture-grown HCV or expressing HCV core protein also displayed significant repression of C9 mRNA and protein levels. Promoter analysis suggested that the T cell factor-4 (TCF-4E) transcription factor is responsible for HCV core-mediated C9 promoter regulation. Sera from chronically HCV-infected patients displayed a lower level of C5b-9 and a reduced antimicrobial effect on model organisms compared to unrelated patient sera or sera from healthy volunteers. Together, these results for C9 regulation by HCV core protein coupled with functional impairment of the membrane attack complex underscore HCV-mediated attenuation of immune mechanisms.
丙型肝炎病毒(HCV)蛋白抑制补体成分的表达,这可能减弱对感染的免疫。在这项研究中,我们研究了 HCV 是否通过补体成分 C9 调节膜攻击复合物(MAC)。MAC 由 C5b 至 C9(C5b-9)组成,介导入侵病原体的细胞溶解。与无关疾病或健康对照人类肝脏 RNA 相比,慢性 HCV 感染患者的肝活检标本显示 C9 mRNA 表达水平较低。感染细胞培养生长的 HCV 或表达 HCV 核心蛋白的肝细胞也显示 C9 mRNA 和蛋白水平的显著抑制。启动子分析表明,T 细胞因子-4(TCF-4E)转录因子负责 HCV 核心介导的 C9 启动子调节。与无关患者的血清或健康志愿者的血清相比,慢性 HCV 感染患者的血清中 C5b-9 的水平较低,对模型生物的抗菌作用降低。总之,这些 HCV 核心蛋白对 C9 调节的结果以及膜攻击复合物的功能障碍突出了 HCV 介导的免疫机制减弱。